YahooNovember 5, 2026 at 4:31 PM NY3 Hours Ago
Nike recovery may lag valuation expectations, UBS warns
Nike Inc (NYSE:NKE, XETRA:NKE) recovery could take longer than its 31x price-to-earnings ratio implies, according to UBS, which maintains a "neutral" rating and a $34 price target. The target rests on 18 times UBS's fiscal year 2029 earnings estimate of $1.90 per share, reflecting its view...
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
